January 19, 2026
The anti-aging market size is forecast to grow from USD 84.41 billion in 2026 to USD 137.13 billion by 2035, g...
Read MoreNovember 13, 2025
The hospital services market is predicted to grow from USD 13.19 trillion in 2026 to USD 28.99 trillion by 203...
Read MoreDecember 24, 2025
The smart healthcare market is expected to rise from USD 397.98 billion in 2026 to USD 1833.7 billion by 2035,...
Read MoreJanuary 21, 2026
The medical device CMO and CDMO market is expected to see growth from USD 52.57 billion in 2026 to USD 110.82 ...
Read MoreNovember 01, 2025
Based on market forecasts, the genome sequencing sector will expand from USD 22.63 billion in 2024 to USD 101.93 billion by 2034, experiencing a CAGR of 16.24%. In 2024, North America led the genome sequencing market, with consumables and next-generation sequencing as key segments. The clinical and academic research sectors dominated. Asia Pacific ...
November 01, 2025
Based on market forecasts, the monoclonal antibodies therapeutics sector will expand from USD 265.17 billion in 2024 to USD 1057.91 billion by 2034, experiencing a CAGR of 14.84%. In 2024, North America led the monoclonal antibody therapeutics market, with human mABs and cancer applications holding the largest shares. Asia Pacific is set for the fa...
November 01, 2025
Based on market forecasts, the pharma 4.0 sector will expand from USD 12.76 billion in 2024 to USD 72.58 billion by 2034, experiencing a CAGR of 19%. In 2024, North America led the Pharma 4.0 market, while Asia-Pacific is set for the fastest growth. Software dominated by type, but services will rise. AI & ML led in technology, with blockchain g...
November 01, 2025
According to market projections, the isotope sector is expected to grow from USD 6.09 billion in 2024 to USD 14.2 billion by 2034, reflecting a CAGR of 8.84%. In 2024, North America led the global isotope market, while Asia-Pacific is set for the fastest growth. Radioisotopes dominated, but stable isotopes are expected to rise. Diagnostics held the...
November 01, 2025
Market insights predict the global progesterone industry will increase from USD 1.52 billion in 2024 to USD 5.05 billion by 2034, achieving a CAGR of 12.74%. In 2024, North America led the progesterone market, while Asia Pacific is set for the fastest growth. Natural formulations held the largest share, but synthetic ones will grow quickest. Inject...
November 01, 2025
According to market projections, the global ectopic pregnancy market, valued at USD 9.03 billion in 2024, is anticipated to reach USD 16.09 billion by 2034, growing at a CAGR of 5.94% over the next decade. In 2024, North America led the ectopic pregnancy market, with tubal ectopic cases and folic acid analogue treatments dominating. Retail pharmaci...
November 01, 2025
According to market projections, the hormonal replacement therapy sector is expected to grow from USD 24.26 billion in 2024 to USD 46.32 billion by 2034, reflecting a CAGR of 6.68%. In 2024, North America led the hormonal replacement therapy market with a 40% share, while Asia Pacific is set for the fastest growth. Estrogen and progesterone therapy...
November 01, 2025
Based on market forecasts, the cutaneous squamous cell carcinoma treatment sector will expand from USD 13.69 billion in 2024 to USD 27.54 billion by 2034, experiencing a CAGR of 7.24%. In 2024, North America led the cutaneous squamous cell carcinoma treatment market, while Asia-Pacific is set for the fastest growth. Non-surgical treatments dominate...
November 01, 2025
According to market projections, the U.S. patient monitoring devices sector is expected to grow from USD 21.4 billion in 2024 to USD 44.68 billion by 2034, reflecting a CAGR of 7.64%. In 2024, multi-parameter monitoring devices led the market, while cardiac monitoring devices are set for strong growth. Hospitals held the largest market share, but h...
November 01, 2025
According to market projections, the global dementia treatments market, valued at USD 18.09 billion in 2024, is anticipated to reach USD 39.16 billion by 2034, growing at a CAGR of 8.03% over the next decade. In 2024, North America led the dementia treatments market (39%), while Asia Pacific is the fastest-growing region. Alzheimer’s disease ...